Maternal obesity affects fetal neurodevelopmental and metabolic gene expression: A pilot study

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Edlow, Andrea G ^a   Vora, Neeta L ^a,c   Hui, Lisa ^a,d   Wick, Heather C ^b   Cowan, Janet M ^a   Bianchi, Diana W ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b Tufts University   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d MERCY HOSPITAL FOR WOMEN   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN D; ESTROGEN RECEPTOR; RNA;

ADULT; AMNIOCENTESIS; AMNION FLUID; APOLIPOPROTEIN D GENE; APOPTOSIS; ARTICLE; BODY MASS; BRAIN CORTEX; CELL DEATH; CELL FUNCTION; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; FETUS; FETUS DEVELOPMENT; FOS GENE; GENDER; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GESTATIONAL AGE; HIGH RISK PREGNANCY; HUMAN; HUMAN TISSUE; KARYOTYPE; LEAN BODY WEIGHT; LIPID ANALYSIS; MALE; MATERNAL OBESITY; METABOLISM; NERVE CELL DIFFERENTIATION; NUCLEOTIDE SEQUENCE; PILOT STUDY; PREDICTION; PREGNANT WOMAN; PRINCIPAL COMPONENT ANALYSIS; PROSPECTIVE STUDY; RNA TRANSLATION; SECOND TRIMESTER PREGNANCY; STAT3 GENE; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; UPREGULATION; ANTIBODY SPECIFICITY; BIOLOGY; DNA MICROARRAY; EMBRYOLOGY; MIDDLE AGED; MOTHER; NERVOUS SYSTEM; OBESITY; PREGNANCY; YOUNG ADULT;

ADULT; AMNIOCENTESIS; COMPUTATIONAL BIOLOGY; FEMALE; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MIDDLE AGED; MOTHERS; NERVOUS SYSTEM; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SPECIFICITY; PILOT PROJECTS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; YOUNG ADULT;

EID: 84897808101     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088661     Document Type: Article

References (78)

1. Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 307: 491-497.
2. Kim SY, Dietz PM, England L, Morrow B, Callaghan WM (2007) Trends in pre-pregnancy obesity in nine states, 1993-2003. Obesity (Silver Spring) 15: 986-993. (Pubitemid 46740974)
3. Gluckman PD, Hanson MA, Cooper C, Thornburg KL (2008) Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 359: 61-73.
4. Boney CM, Verma A, Tucker R, Vohr BR (2005) Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 115: e290-296. (Pubitemid 43373011)
5. Crespo PS, Prieto Perera JA, Lodeiro FA, Azuara LA (2007) Metabolic syndrome in childhood. Public Health Nutr 10: 1121-1125. (Pubitemid 350085199)
6. Lawlor DA, Smith GD, O'Callaghan M, Alati R, Mamun AA, et al. (2007) Epidemiologic evidence for the fetal overnutrition hypothesis: findings from the mater-university study of pregnancy and its outcomes. Am J Epidemiol 165: 418-424.
7. Tanda R, Salsberry PJ, Reagan PB, Fang MZ (2013) The Impact of Prepregnancy Obesity on Children's Cognitive Test Scores. Matern Child Health J 17: 222-229.
8. Heikura U, Taanila A, Hartikainen AL, Olsen P, Linna SL, et al. (2008) Variations in prenatal sociodemographic factors associated with intellectual disability: a study of the 20-year interval between two birth cohorts in northern Finland. Am J Epidemiol 167: 169-177.
9. Neggers YH, Goldenberg RL, Ramey SL, Cliver SP (2003) Maternal prepregnancy body mass index and psychomotor development in children. Acta Obstet Gynecol Scand 82: 235-240. (Pubitemid 36459730)
10. Krakowiak P, Walker CK, Bremer AA, Baker AS, Ozonoff S, et al. (2012) Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders. Pediatrics 129: e1121-1128.
11. Hinkle SN, Schieve LA, Stein AD, Swan DW, Ramakrishnan U, et al. (2012) Associations between maternal prepregnancy body mass index and child neurodevelopment at 2 years of age. Int J Obes (Lond) 36: 1312-1319.
12. Rodriguez A, Miettunen J, Henriksen TB, Olsen J, Obel C, et al. (2008) Maternal adiposity prior to pregnancy is associated with ADHD symptoms in offspring: evidence from three prospective pregnancy cohorts. Int J Obes (Lond) 32: 550-557. (Pubitemid 351414811)
13. Larrabee PB, Johnson KL, Lai C, Ordovas J, Cowan JM, et al. (2005) Global gene expression analysis of the living human fetus using cell-free messenger RNA in amniotic fluid. JAMA 293: 836-842. (Pubitemid 40250367)
14. Hui L, Slonim DK, Wick HC, Johnson KL, Bianchi DW (2012) The amniotic fluid transcriptome: a source of novel information about human fetal development. Obstet Gynecol 119: 111-118.
15. Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, et al. (2009) Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses. Proc Natl Acad Sci U S A 106: 9425-9429.
16. Koide K, Slonim DK, Johnson KL, Tantravahi U, Cowan JM, et al. (2011) Transcriptomic analysis of cell-free fetal RNA suggests a specific molecular phenotype in trisomy 18. Hum Genet 129: 295-305.
17. Hui L, Slonim DK, Wick HC, Johnson KL, Koide K, et al. (2012) Novel neurodevelopmental information revealed in amniotic fluid supernatant transcripts from fetuses with trisomies 18 and 21. Hum Genet 131: 1751-1759.
18. Bianchi DW, LeShane ES, Cowan JM (2001) Large amounts of cell-free fetal DNA are present in amniotic fluid. Clin Chem 47: 1867-1869. (Pubitemid 32881208)
19. Zhong XY, Holzgreve W, Tercanli S, Wenzel F, Hahn S (2006) Cell-free foetal DNA in maternal plasma does not appear to be derived from the rich pool of cell-free foetal DNA in amniotic fluid. Arch Gynecol Obstet 273: 221-226. (Pubitemid 43004694)
20. Lun FM, Chiu RW, Leung TY, Leung TN, Lau TK, et al. (2007) Epigenetic analysis of RASSF1A gene in cell-free DNA in amniotic fluid. Clin Chem 53: 796-798. (Pubitemid 46580258)
21. Makrydimas G, Gerovassili A, Sotiriadis A, Kavvadias A, Nicolaides KH (2008) Cell-free fetal DNA in celomic fluid. Ultrasound Obstet Gynecol 32: 594-595.
22. Flori E, Doray B, Gautier E, Kohler M, Ernault P, et al. (2004) Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytiotrophoblastic cells. Case report. Hum Reprod 19: 723-724. (Pubitemid 38344540)
23. Guibert J, Benachi A, Grebille AG, Ernault P, Zorn JR, et al. (2003) Kinetics of SRY gene appearance in maternal serum: detection by real time PCR in early pregnancy after assisted reproductive technique. Hum Reprod 18: 1733-1736. (Pubitemid 36958060)
24. Masuzaki H, Miura K, Yoshiura KI, Yoshimura S, Niikawa N, et al. (2004) Detection of cell free placental DNA in maternal plasma: direct evidence from three cases of confined placental mosaicism. J Med Genet 41: 289-292. (Pubitemid 38496774)
25. Edlow AG, Bianchi DW (2012) Tracking fetal development through molecular analysis of maternal biofluids. Biochim Biophys Acta 1822: 1970-1980.
26. Pavlidis P, Li Q, Noble WS (2003) The effect of replication on gene expression microarray experiments. Bioinformatics 19: 1620-1627. (Pubitemid 37121149)
27. Massingham LJ, Johnson KL, Bianchi DW, Pei S, Peter I, et al. (2011) Proof of concept study to assess fetal gene expression in amniotic fluid by nanoarray PCR. J Mol Diagn 13: 565-570.
28. Dietz JA, Johnson KL, Massingham LJ, Schaper J, Horlitz M, et al. (2011) Comparison of extraction techniques for amniotic fluid supernatant demonstrates improved yield of cell-free fetal RNA. Prenat Diagn 31: 598-599.
29. Peter I, Tighiouart H, Lapaire O, Johnson KL, Bianchi DW, et al. (2008) Cell-free DNA fragmentation patterns in amniotic fluid identify genetic abnormalities and changes due to storage. Diagn Mol Pathol 17: 185-190.
30. Lapaire O, Bianchi DW, Peter I, O'Brien B, Stroh H, et al. (2007) Cell-free fetal DNA in amniotic fluid: unique fragmentation signatures in euploid and aneuploid fetuses. Clin Chem 53: 405-411. (Pubitemid 46447936)
31. Hui L, Wick HC, Edlow AG, Cowan JM, Bianchi DW (2013) Global gene expression analysis of term amniotic fluid cell-free fetal RNA. Obstet Gynecol 121: 1248-1254.
32. Hui L, Wick HC, Moise KJ Jr, Johnson A, Luks F, et al. (2013) Global gene expression analysis of amniotic fluid cell-free RNA from recipient twins with twin-twin transfusion syndrome. Prenat Diagn.
33. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
34. Gentleman R (2005) Reproducible research: a bioinformatics case study. Stat Appl Genet Mol Biol 4: Article2.
35. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc Ser B (Methodological) 57: 289-300.
36. Jolliffee IT (2002) Principal Component Analysis, Second Edition. New York: Springer-Verlag.
37. IPA website (2013) Calculating and Interpreting the p-values for Functions, Pathways, and Lists in IPA. Available: http://www.ingenuity.com/wp- content/themes/ingenuitytheme/pdf/ipa/functions-pathways-pval-whitepaper.pdf. Accessed 2013 Mar 14.
38. IPA website (2013) Ingenuity Upstream Regulator Analysis Whitepaper. Available: http://pages.ingenuity.com/ IngenuityUpstreamRegulatorAnalysisWhitepaper.html. Accessed 2013 Jan 1.
39. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, et al. (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 101: 6062-6067. (Pubitemid 38520528)
40. Kislinger T, Cox B, Kannan A, Chung C, Hu P, et al. (2006) Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling. Cell 125: 173-186.
41. Pennings JL, Kuc S, Rodenburg W, Koster MP, Schielen PC, et al. (2011) Integrative data mining to identify novel candidate serum biomarkers for preeclampsia screening. Prenat Diagn 31: 1153-1159.
42. Affymetrix (2012) NA33 release for the HG U133 Plus 2.0, October 30, 2012.
43. Rassart E, Bedirian A, Do Carmo S, Guinard O, Sirois J, et al. (2000) Apolipoprotein D. Biochim Biophys Acta 1482: 185-198.
44. Wu C, Orozco C, Boyer J, Leglise M, Goodale J, et al. (2009) BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 10: R130.
45. Eurexpress website (2013) Available: http://www.eurexpress.org/ee/ databases/assay.jsp?assayID=euxassay-001865&image=01. Accessed 2013, Jan 15.
46. He X, Jittiwat J, Kim JH, Jenner AM, Farooqui AA, et al. (2009) Apolipoprotein D modulates F2-isoprostane and 7-ketocholesterol formation and has a neuroprotective effect on organotypic hippocampal cultures after kainate-induced excitotoxic injury. Neurosci Lett 455: 183-186.
47. Kosacka J, Gericke M, Nowicki M, Kacza J, Borlak J, et al. (2009) Apolipoproteins D and E3 exert neurotrophic and synaptogenic effects in dorsal root ganglion cell cultures. Neuroscience 162: 282-291.
48. Khan MM, Parikh VV, Mahadik SP (2003) Antipsychotic drugs differentially modulate apolipoprotein D in rat brain. J Neurochem 86: 1089-1100. (Pubitemid 37022185)
49. Choi KH, Zepp ME, Higgs BW, Weickert CS, Webster MJ (2009) Expression profiles of schizophrenia susceptibility genes during human prefrontal cortical development. J Psychiatry Neurosci 34: 450-458.
50. Mahadik SP, Khan MM, Evans DR, Parikh VV (2002) Elevated plasma level of apolipoprotein D in schizophrenia and its treatment and outcome. Schizophr Res 58: 55-62.
51. Thomas EA, Dean B, Pavey G, Sutcliffe JG (2001) Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders. Proc Natl Acad Sci U S A 98: 4066-4071. (Pubitemid 32249899)
52. Ordonez C, Navarro A, Perez C, Astudillo A, Martinez E, et al. (2006) Apolipoprotein D expression in substantia nigra of Parkinson disease. Histol Histopathol 21: 361-366.
53. Thomas EA, Laws SM, Sutcliffe JG, Harper C, Dean B, et al. (2003) Apolipoprotein D levels are elevated in prefrontal cortex of subjects with Alzheimer's disease: no relation to apolipoprotein E expression or genotype. Biol Psychiatry 54: 136-141. (Pubitemid 36859773)
54. Kim WS, Wong J, Weickert CS, Webster MJ, Bahn S, et al. (2009) Apolipoprotein-D expression is increased during development and maturation of the human prefrontal cortex. J Neurochem 109: 1053-1066.
55. White CL, Pistell PJ, Purpera MN, Gupta S, Fernandez-Kim SO, et al. (2009) Effects of high fat diet on Morris maze performance, oxidative stress, and inflammation in rats: contributions of maternal diet. Neurobiol Dis 35: 3-13.
56. Patel MP, Masood A, Patel PS, Chanan-Khan AA (2009) Targeting the Bcl-2. Curr Opin Oncol 21: 516-523.
57. Niculescu MD, Lupu DS (2009) High fat diet-induced maternal obesity alters fetal hippocampal development. Int J Dev Neurosci 27: 627-633.
58. Stachowiak EK, Oommen S, Vasu VT, Srinivasan M, Stachowiak M, et al. (2012) Maternal obesity affects gene expression and cellular development in fetal brains. Nutr Neurosci 16: 96-103.
59. Blaschke AJ, Weiner JA, Chun J (1998) Programmed cell death is a universal feature of embryonic and postnatal neuroproliferative regions throughout the central nervous system. J Comp Neurol 396: 39-50. (Pubitemid 28242450)
60. Rice D, Barone S Jr (2000) Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 108 Suppl 3: 511-533. (Pubitemid 30466179)
61. Herbst AL, Ulfelder H, Poskanzer DC (1971) Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 284: 878-881.
62. Newbold RR (2011) Developmental exposure to endocrine-disrupting chemicals programs for reproductive tract alterations and obesity later in life. Am J Clin Nutr 94: 1939S-1942S.
63. Durchdewald M, Angel P, Hess J (2009) The transcription factor Fos: a Janus-type regulator in health and disease. Histol Histopathol 24: 1451-1461.
64. Morton GJ, Schwartz MW (2010) Leptin and the central nervous system control of glucose metabolism. Physiol Rev 91: 389-411.
65. Hastings NE, Simmers MB, McDonald OG, Wamhoff BR, Blackman BR (2007) Atherosclerosis-prone hemodynamics differentially regulates endothelial and smooth muscle cell phenotypes and promotes pro-inflammatory priming. Am J Physiol Cell Physiol 293: C1824-1833. (Pubitemid 350255075)
66. Min W, Bin ZW, Quan ZB, Hui ZJ, Sheng FG (2009) The signal transduction pathway of PKC/NF-kappa B/c-fos may be involved in the influence of high glucose on the cardiomyocytes of neonatal rats. Cardiovasc Diabetol 8: 8.
67. Greenhill CJ, Rose-John S, Lissilaa R, Ferlin W, Ernst M, et al. (2011) IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3. J Immunol 186: 1199-1208.
68. Hirano T, Ishihara K, Hibi M (2000) Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19: 2548-2556. (Pubitemid 30339210)
69. Kirk SL, Samuelsson AM, Argenton M, Dhonye H, Kalamatianos T, et al. (2009) Maternal obesity induced by diet in rats permanently influences central processes regulating food intake in offspring. PLoS One 4: e5870.
70. Clementi AH, Gaudy AM, van Rooijen N, Pierce RH, Mooney RA (2009) Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling. Biochim Biophys Acta 1792: 1062-1072.
71. Perdomo G, Kim DH, Zhang T, Qu S, Thomas EA, et al. (2010) A role of apolipoprotein D in triglyceride metabolism. J Lipid Res 51: 1298-1311.
72. Baker WA, Hitman GA, Hawrami K, McCarthy MI, Riikonen A, et al. (1994) Apolipoprotein D gene polymorphism: a new genetic marker for type 2 diabetic subjects in Nauru and south India. Diabet Med 11: 947-952. (Pubitemid 24375832)
73. Vijayaraghavan S, Hitman GA, Kopelman PG (1994) Apolipoprotein-D polymorphism: a genetic marker for obesity and hyperinsulinemia. J Clin Endocrinol Metab 79: 568-570. (Pubitemid 24256554)
74. Liu Z, Chang GQ, Leibowitz SF (2001) Apolipoprotein D interacts with the long-form leptin receptor: a hypothalamic function in the control of energy homeostasis. FASEB J 15: 1329-1331.
75. Heerwagen MJ, Miller MR, Barbour LA, Friedman JE (2010) Maternal obesity and fetal metabolic programming: a fertile epigenetic soil. Am J Physiol Regul Integr Comp Physiol 299: R711-722.
76. Armitage JA, Poston L, Taylor PD (2008) Developmental origins of obesity and the metabolic syndrome: the role of maternal obesity. Front Horm Res 36: 73-84.
77. Romero R, Tromp G (2006) High-dimensional biology in obstetrics and gynecology: functional genomics in microarray studies. Am J Obstet Gynecol 195: 360-363. (Pubitemid 44160683)
78. Olson NE (2006) The microarray data analysis process: from raw data to biological significance. NeuroRx 3: 373-383. Development Development